161 related articles for article (PubMed ID: 35900480)
1. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition.
Liu M; Zhang M; Yin H
Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480
[TBL] [Abstract][Full Text] [Related]
2. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
[No Abstract] [Full Text] [Related]
3. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
4. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling.
Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T
Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257
[TBL] [Abstract][Full Text] [Related]
5. Linc-ROR Promotes EMT by Targeting miR-204-5p/SMAD4 in Endometriosis.
Yi M; Wang S; Zhang X; Jiang L; Xia X; Zhang T; Fang X
Reprod Sci; 2023 Sep; 30(9):2665-2679. PubMed ID: 36917423
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
8. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.
Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F
Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051
[TBL] [Abstract][Full Text] [Related]
9. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
[TBL] [Abstract][Full Text] [Related]
10. LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
Cell Physiol Biochem; 2017; 41(6):2399-2410. PubMed ID: 28463831
[TBL] [Abstract][Full Text] [Related]
11. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
13. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
[TBL] [Abstract][Full Text] [Related]
14. linc‑ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1‑mediated epithelial‑mesenchymal transition.
Zhang Y; Wu W; Sun Q; Ye L; Zhou D; Wang W
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760121
[TBL] [Abstract][Full Text] [Related]
15. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
17. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
18. Linc-ROR Regulates
Yu X; Ma X; Jia Y; Wu X; Yan Z
Cell Transplant; 2023; 32():9636897231178902. PubMed ID: 37306240
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 Promoted the Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer via Activating Wnt/β-Catenin Signaling.
Liu J; Wang G; Zhao J; Liu X; Zhang K; Gong G; Pan H; Jiang Z
Dig Dis; 2022; 40(4):436-447. PubMed ID: 34348271
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
